MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$1,079,248
(39.21%↑ Y/Y)
Net loss
attributable to...
-$108,691
(47.36%↑ Y/Y)
Net loss
-$1,187,939
(40.06%↑ Y/Y)
Loss before
provision for income tax
-$1,187,939
(40.06%↑ Y/Y)
Sales of products and
services
$12,353
(255.99%↑ Y/Y)
Loss from operations
-$1,187,696
(32.90%↑ Y/Y)
Total other income
(expenses)
-$243
(99.89%↑ Y/Y)
Gross profit
$8,165
(208.35%↑ Y/Y)
Cost of goods and
services sold
$4,188
(409.49%↑ Y/Y)
Total operating
expenses
$1,195,861
(-32.54%↓ Y/Y)
Interest income
(expense)
-$243
(-586.00%↓ Y/Y)
Employee compensation
$766,888
(-10.55%↓ Y/Y)
Depreciation and
amortization of property and...
$167,581
(-1.35%↓ Y/Y)
Other operating
expenses
$135,166
(-60.45%↓ Y/Y)
Occupancy
$116,034
(-70.26%↓ Y/Y)
Amortization of intangible
assets
$10,192
(-24.06%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)